Oral and Maxillofacial squamous cell carcinoma is one of the more common malignant tumors of the maxillofacial region, which develops a high lymph node metastasis rate due to the specificity of the site of occurrence and the richness of the lymphatic traffic network in the neck. Its treatment is mainly based on surgery and radiotherapy and chemotherapy. There are various views on the selection of the extent of lymph node dissection during surgery, and the literature reports that the depth of infiltration of cancer cells has a great influence on lymphatic metastasis, and the AJCC released the latest version of the TNM staging with the addition of the DOI index in the T stage, which has set the direction for the extent of lymphatic dissection. The impact of metastatic lymph node ENE on healing and the psychological pressure and burden of life faced by postoperative patients are also of great concern. In this article, we review the findings of oral and maxillofacial SCC in recent years.

Zulifeiya Alimu, Maimaitituxun Tuerdi. Progress in the study of lymph node metastasis status of squamous cell carcinoma of the oral and maxillofacial region. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 12: 116-119. https://doi.org/10.25236/AJMHS.2023.041216.

[1] Wang Xiangjun. Clinicopathological analysis of 1447 cases of oral and maxillofacial malignant tumours[D]. Henan:Zhengzhou University,2012.

[2] Yao M, Luo Y, Shan J. Analysis of 1977 cases of oral and maxillofacial malignant tumours[J]. China Hospital Statistics,2010,17(3):280-281.

[3] HUANG Liping,XU Xuanli,TU Wenyong. Retrospective analysis of 330 cases of oral and maxillofacial malignant tumours[J]. Chinese Journal of Integrative Otolaryngology, 2021,29(2):132- 135,140.

[4] SUN Xiaodong. Clinical research on oral and maxillofacial malignant tumours[J]. China Practical Medicine,2015(16):129-130.

[5] Chen Xiaotao,Liu Zhaoyong,Yang Min.Statistical analysis of 2123 cases of oral and maxillofacial tumours[J]. Journal of Xinjiang Medical University, 2014, 37(06):740-743.

[6] SU Weipeng,LIU Pan,ZHAO Huarong et al. Epidemiological analysis of 2829 cases of head and neck malignant tumours in Xinjiang[J]. China Cancer Clinic,2013,40(19):1165.1169.

[7] WANG Xiaoying,LUO Yi. Statistical analysis of oral and maxillofacial malignant tumours[J]. China Hospital Statistics,2013(4):274-276.

[8] Zou Shiqi, Mao Chi et al. Clinical observation on extraperitoneal spread of neck metastatic lymph nodes of oral cancer[J]. Journal of Modern Stomatology, 2008, 22(2): 117.119.

[9] HE Hong,CHEN Guanfu,ZHOU Ying et al.Composition of 9056 cases of oral and maxillofacial tumour-like diseases during 52 years[J]. Journal of Practical Oncology,2007,22(6):532.536.

[10] Li X.J.. Study on factors related to cervical lymphatic metastasis of oral squamous cell carcinoma [D]. Hunan:Central South University,2013.

[11] Yao M, Luo Y, Shan J. Analysis of 1977 cases of oral and maxillofacial malignant tumours[J]. China Hospital Statistics,2010,17(3):280-281.

[12] Kaidar-Person O, Gil Z, Billan S. Precision medicine in head and neck cancer[J]. Drug Resistance Updates, 2018, 40: 13-16.

[13] Jian Xinchun,Jian Yu. Multidisciplinary collaborative treatment of oral and maxillofacial-head and neck malignant tumours[J]. Chinese Medical Journal, 2021,23(11):1601-1604.

[14] Rettig EM, G D'Souza. Epidemiology of Head and Neck Cancer[J]. Surgical Oncology Clinics ,2015, 24(3): 379-396.

[15] J Pr Klussmann. Head and Neck Cancer - New Insights into a Heterogeneous Disease[J]. Oncology Research and Treatment, 2017, 40(6): 318-319.

[16] Shanthi Marur, Arlene A. Forastiere. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment[J]. Mayo Clinic Proceedings, 2016, 91(3): 386-396.

[17] Paolo Bossi, Salvatore Alfieri, Primoz Strojan. Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature[J]. Critical Reviews in Oncology/ Hematology, 2019, 137: 84-91.

[18] Davide Franceschini, Fabiola Paiar, Calogero Saieva. Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy[J]. La Radiologcal medicine, 2016, 121(3): 229-237.

[19] Volker Budach, Ingeborg Tinhofer. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review[J]. Lancet Oncology, 2019, 20(6): 313- 326.

[20] Lars Axelsson, Jan Nyman, Hedda Haugen-Cange. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection[J]. Journal of Otolaryngology Head &Neck Surgery, 2017, 46(1): 45.

[21] LI Yu-An,GUO Chuan-Jian,GAO Yan. Correlation between the extent of cervical lymphatic metastasis and clinicopathological factors in oral squamous cell carcinoma[J]. Journal of Modern Stomatology,2005,19(3):225-227.

[22] Snow G B, Patel P, Leemans C R, et al. Management of cervical lymph nodes in patients with head and neck cancer[J]. European archives of oto-rhino-laryngology, 1992, 249: 187-194.

[23] Ebrahimi A, Clark JR, Amit M, et al. Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study[J]. Ann Surgery Oncology, 2014, 21(9): 3049-3055.

[24] LOU Zhi-Hong,ZHENG Yu-Bo,LIU Hui-Lin et al. Effects of group psychotherapy on coping styles, stress responses and meaning of life in tongue cancer patients[J]. International Journal of Psychiatry, 2022,49(06):1099-1101+1106.

[25] LI Qun,CHEN Linlin. Analysis of clinical and pathological factors affecting lymph node metastasis of squamous cell carcinoma of the tongue[J]. Modern Diagnosis and Treatment, 2001, 12(6): 351.352.

[26] Byers RM,E1-Naggar AK,Lee YY eta1.Can we detector predict the presence of occult nodal metastasis in patients with squamous carcinoma of the oral tongue?[J].Head Neck, 1998,20:138-144.